🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study will evaluate if a combination of saxagliptin and dapagliflozin added...
Status
Completed
Location
Research Site
Start Date
2014-09-09
Trial ID
NCT02284893
The purpose of this study is to learn if BMS-512148 (Dapagliflozin) as part...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2012-09
Trial ID
NCT01646320
Treatments Being Tested
To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118)...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT01434186
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
Research Site
Start Date
2011-06
Trial ID
NCT01204775
Treatments Being Tested
Saxagliptin is a new investigational medication being developed for treatme...
Status
Completed
Location
Research Site
Start Date
2008-01
Trial ID
NCT00614939
Treatments Being Tested
This is a 24 week, multicenter, randomized, double-blind, parallel group, p...
Status
Completed
Location
Research Site
Start Date
2017-01-10
Trial ID
NCT02917031
Treatments Being Tested
This is a 24-week, multicenter, randomized, double-blind, double-dummy, pla...
Status
Terminated
Location
Research Site
Start Date
2019-02-27
Trial ID
NCT03608358
The purpose of this study is to learn if a combination of BMS-477118 (Saxag...
Status
Completed
Location
Central Alabama Research
Start Date
2012-07
Trial ID
NCT01606007
The primary objective of this study is to determine if there will be a grea...
Status
Completed
Location
Research Site
Start Date
2017-10-11
Trial ID
NCT03199053
Treatments Being Tested
The purpose of this clinical research study is to determine whether dapagli...
Status
Completed
Location
Research Site
Start Date
2015-09-21
Trial ID
NCT02547935